Nurse-led stigma-reduction education for adults with epilepsy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with epilepsy are randomized to receive four weekly nurse-led education sessions or routine care. The program covers epilepsy knowledge, stigma and self-stigma, disclosure, communication, medication adherence, triggers, stress management, seizure diaries, and personalized self-management planning. Outcomes will be measured with validated tools to assess stigma, concealment, and self-management after the program. The study uses standard randomized controlled methods to compare the intervention with control over the study period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 years or older
* Diagnosed with epilepsy at least 6 months before enrollment
* Able to communicate and participate in the education program without a cognitive or psychiatric condition that would prevent participation
* Able to read and understand Turkish
* Willing to participate in the study
* Provides written informed consent

Exclusion Criteria:

* Presence of a severe neurological disorder other than epilepsy
* Presence of a serious psychiatric disorder
* Advanced cognitive impairment or any condition preventing effective communication
* Unable to attend the educational sessions regularly
* Major change in the treatment protocol during the study
* Incomplete completion of data collection forms
* Withdrawal from the study at any stage

Where it's running

• Malatya Training and Research Hospital
  Malatya, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Cihat Demirel, PhD
• Email: cihatdemirel34@gmail.com
• Phone: +905536186477

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• RAP-219 long-acting injectable safety and PK study in healthy adults

  This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.

  Recruiting Phase 1 Rapport Therapeutics Inc. · Adelaide · NCT07923097

• Why People with Epilepsy Get More Infections

  This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.

  Recruiting University of Aberdeen · Aberdeen · NCT07903168

• Long-Term Epilepsy Outcomes in Children After Perinatal Stroke

  This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07898397

• Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy

  This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens, Picardie · NCT07888543

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Advanced 7T fMRI for brain function in epilepsy and brain injuries

  This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.

  Recruiting Imago 7 Fondazione di Ricerca onlus · Pisa, Italy · NCT07865546

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.